With the discovery that thyroid hormone (TH) signal change in cells can be a possible factor in developing liver-related diseases such as NAFLD, the role of thyroid hormones has been constantly studied for the treatment of NASH, which is a subset of NAFLD. This evidence concerns the gene TG and metabolic dysfunction-associated steatohepatitis.